Immunotherapy Clearance and Phenotype of Circulating Tumor Cells in Lung and Head and Neck Cancers

NAActive, not recruitingINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

October 27, 2021

Primary Completion Date

December 11, 2026

Study Completion Date

December 11, 2026

Conditions
Metastatic NSCLCMetastatic Head and Neck Cancer
Interventions
OTHER

Blood draws

"Blood draws will be realized at the following time points:~C1T1: at the baseline, before treatment administration. C1T2: cycle 1, after treatment administration. C2T1: the day of the 2nd cycle, before treatment administration. C2T2: the day of 2nd cycle, after treatment administration. C3T1: the day of the 3rd cycle, before treatment administration. C3T2: the day of 3rd cycle, after treatment administration."

Trial Locations (2)

Unknown

Croix Rousse Hospital, Lyon

Lyon Sud Hospital, Pierre-Bénite

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER